industry
Popular up and coming topics, concerns, and products in the health and wellness industry.
Japan Molecular Diagnostics Market Size & Forecast 2025–2033. AI-Generated.
Japan Molecular Diagnostics Market Overview The Japan Molecular Diagnostics Market is entering a phase of sustained and technology-driven expansion. According to Renub Research, the market is anticipated to grow from US$ 757.42 million in 2024 to US$ 1,291.65 million by 2033, registering a CAGR of 6.11% during 2025–2033.
By Aaina Oberoi20 days ago in Longevity
United States Alzheimer’s Drugs Market Size & Forecast 2025–2033. AI-Generated.
United States Alzheimer’s Drugs Market Outlook The United States Alzheimer’s Drugs Market is entering a pivotal transformation phase, supported by scientific breakthroughs, demographic shifts, and heightened public health prioritization. According to Renub Research estimates, the market is projected to expand from US$ 2.28 billion in 2024 to US$ 4.47 billion by 2033, registering a CAGR of 7.78% during 2025–2033.
By Renub Research22 days ago in Longevity
Mexico Active Pharmaceutical Ingredients Market Size & Forecast 2025–2033. AI-Generated.
Mexico Active Pharmaceutical Ingredients Market Outlook The Mexico Active Pharmaceutical Ingredients (API) Market is poised for sustained growth over the coming decade, reflecting the country’s expanding pharmaceutical manufacturing base and increasing healthcare demand. According to Renub Research, the market is expected to grow from US$ 4.39 billion in 2024 to US$ 7.42 billion by 2033, registering a compound annual growth rate (CAGR) of 6.02% during 2025–2033.
By Renub Research22 days ago in Longevity
Japan Insulin Pen Market Size & Forecast 2025–2033. AI-Generated.
Japan Insulin Pen Market Outlook The Japan Insulin Pen Market is forecasted to grow from US$ 304.26 million in 2024 to US$ 515.35 million by 2033, registering a compound annual growth rate (CAGR) of 6.03% during the forecast period 2025–2033. This steady expansion is primarily driven by Japan’s rapidly aging population, rising prevalence of diabetes, and increasing preference for advanced, easy-to-use insulin delivery systems.
By Renub Research22 days ago in Longevity
Saudi Arabia Blood Glucose Device Market Size & Forecast 2025–2033. AI-Generated.
Saudi Arabia Blood Glucose Device Market Outlook (2025–2033) The Saudi Arabia Blood Glucose Device Market is projected to expand from US$ 143.96 million in 2024 to US$ 259.8 million by 2033, registering a healthy CAGR of 6.78% during the forecast period 2025–2033, according to Renub Research.
By Renub Research22 days ago in Longevity
United States Continuous Glucose Monitoring Market Size & Forecast 2025–2033. AI-Generated.
United States Continuous Glucose Monitoring Market Outlook The United States Continuous Glucose Monitoring (CGM) Market is poised for robust expansion, projected to grow from US$ 2.05 billion in 2024 to US$ 4.23 billion by 2033, registering a CAGR of 8.36% during the forecast period 2025–2033, according to Renub Research. This sustained growth is driven by the escalating prevalence of diabetes, rapid technological innovations in wearable medical devices, expanding insurance reimbursement, and a decisive shift toward proactive, data-driven chronic disease management.
By Renub Research22 days ago in Longevity
Australia Infant Phototherapy Device Market Size and Forecast 2025–2033. AI-Generated.
Australia Infant Phototherapy Device Market Overview The Australia Infant Phototherapy Device Market is estimated to reach US$ 2.47 billion by 2033, rising from US$ 1.88 billion in 2024, and expanding at a CAGR of 3.1% during 2025–2033. Market growth is primarily supported by the rising prevalence of neonatal jaundice, increasing awareness of early infant healthcare, and continued advancements in safe, non-invasive phototherapy technologies across Australian hospitals and neonatal intensive care units (NICUs).
By Janine Root 22 days ago in Longevity
United States Insulin Pump Market Size and Forecast 2025–2033. AI-Generated.
United States Insulin Pump Market Outlook The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion by 2033, expanding at a CAGR of 5.84% during 2025–2033. This steady growth is driven by the rising prevalence of diabetes, rapid advancements in insulin delivery technologies, and increasing awareness of continuous glucose monitoring (CGM) and personalized diabetes management across the U.S. healthcare ecosystem.
By Janine Root 22 days ago in Longevity
